ArticleCureus2025
Comparative Analysis of Outcomes and Influencing Factors in COVID-Associated Rhino-Orbital-Cerebral Mucormycosis: Globe Salvage Versus Exenteration.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Survival and renal outcomes of mucormycosis infection and its treatment regimens in resource-limited settings: a retrospective case series.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim This study aimed to evaluate and compare the outcomes of globe-salvaging procedures versus orbital exenteration in patients with COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) during the second wave of the pandemic in India. Methods An ambispective observational study was conducted at a tertiary care hospital in Central India between April and October 2021. Thirty-five consecutive patients with confirmed ROCM and recent COVID-19 infection were enrolled. Based on the extent of orbital involvement and surgical judgment, patients were categorized into either the Globe Salvage Group or the Exenteration Group. Clinical characteristics, comorbidities, treatment details, and outcomes were recorded, with a minimum follow-up of six months. The primary outcome was survival; secondary outcomes included disease recurrence, disease control, and postoperative complications. Statistical analyses were performed using IBM SPSS Statistics for Windows, Version 23.0 (Released 2015; IBM Corp., Armonk, NY, USA). This study adheres to the STrengthening the Reporting of OBservational studies in Epidemiology(STROBE) guidelines. Results The mean age of patients was 48.77 years, and 82.9% were male. Diabetes and prior corticosteroid use were present in 82.9% of patients. All cases were advanced ROCM (Stage III/IV). Of the 35 patients, 25 (71.4%) underwent globe-salvaging procedures, while 10 (28.6%) underwent orbital exenteration. Overall survival was 82.9%, with higher mortality in the Exenteration Group (40%) compared with the salvage group (8%). Disease recurrence occurred in 10% of the salvage group and 5% of the Exenteration Group. Conclusions When carefully selected, globe-salvaging procedures provide survival outcomes comparable to exenteration, with lower morbidity. Early diagnosis, control of risk factors, and timely intervention are essential to improving outcomes in ROCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.